UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012

Journal of Clinical Microbiology, 2012-09, Vol.50 (9), p.2846-2856

2012

Volltextzugriff (PDF)

Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

Clinical Microbiology Reviews, 2007-01, Vol.20 (1), p.133-163

2007

Volltextzugriff (PDF)

Rare and emerging opportunistic fungal pathogens: Concern for resistance beyond Candida albicans and Aspergillus fumigatus

Journal of clinical microbiology, 2004-10, Vol.42 (10), p.4419-4431

2004

Volltextzugriff (PDF)

In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species

Antimicrobial Agents and Chemotherapy, 2010-06, Vol.54 (6), p.2497-2506

2010

Volltextzugriff (PDF)

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion

Journal of Clinical Microbiology, 2010-04, Vol.48 (4), p.1366-1377

2010

Volltextzugriff (PDF)

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

Journal of Clinical Microbiology, 2010-09, Vol.48 (9), p.3251-3257

2010

Volltextzugriff (PDF)

Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility Testing

Clinical Microbiology Reviews, 2006-04, Vol.19 (2), p.435-447

2006

Volltextzugriff (PDF)

Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida : Time for harmonization of CLSI and EUCAST broth microdilution methods

Drug resistance updates, 2010-12, Vol.13 (6), p.180-195

2010

Volltextzugriff (PDF)

Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints

Journal of Clinical Microbiology, 2008-08, Vol.46 (8), p.2620-2629

2008

Volltextzugriff (PDF)

Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria

Drug resistance updates, 2011-06, Vol.14 (3), p.164-176

2011

Volltextzugriff (PDF)

Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999

Clinical infectious diseases, 2001-05, Vol.32 (Supplement-2), p.S114-S132

2001

Volltextzugriff (PDF)

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins and Candida spp

Journal of Clinical Microbiology, 2010-01, Vol.48 (1), p.52-56

2010

Volltextzugriff (PDF)

In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance

Journal of Clinical Microbiology, 2008-01, Vol.46 (1), p.150-156

2008

Volltextzugriff (PDF)

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing

Journal of Clinical Microbiology, 2009-01, Vol.47 (1), p.117-123

2009

Volltextzugriff (PDF)

Attributable Mortality of Nosocomial Candidemia, Revisited

Clinical infectious diseases, 2003-11, Vol.37 (9), p.1172-1177

2003

Volltextzugriff (PDF)

Activities of Caspofungin, Itraconazole, Posaconazole, Ravuconazole, Voriconazole, and Amphotericin B against 448 Recent Clinical Isolates of Filamentous Fungi

Journal of Clinical Microbiology, 2003-08, Vol.41 (8), p.3623-3626

2003

Volltextzugriff (PDF)

Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

Journal of Clinical Microbiology, 2006-03, Vol.44 (3), p.819-826

2006

Volltextzugriff (PDF)

Seasonality of staphylococcal infections

Clinical microbiology and infection, 2012-10, Vol.18 (10), p.927-933

2012

Volltextzugriff (PDF)

In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance

Journal of Clinical Microbiology, 2006-03, Vol.44 (3), p.760-763

2006

Volltextzugriff (PDF)

Activity of MGCD290, a Hos2 Histone Deacetylase Inhibitor, in Combination with Azole Antifungals against Opportunistic Fungal Pathogens

Journal of Clinical Microbiology, 2009-12, Vol.47 (12), p.3797-3804

2009

Volltextzugriff (PDF)

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution

Journal of Clinical Microbiology, 2012-06, Vol.50 (6), p.2040-2046

2012

Volltextzugriff (PDF)

In Vivo Pharmacodynamic Target Investigation for Micafungin against Candida albicans and C. glabrata in a Neutropenic Murine Candidiasis Model

Antimicrobial Agents and Chemotherapy, 2008-10, Vol.52 (10), p.3497-3503

2008

Volltextzugriff (PDF)

Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location in the United States in 2001 to 2007

Journal of Clinical Microbiology, 2009-10, Vol.47 (10), p.3185-3190

2009

Volltextzugriff (PDF)

Defining and Evaluating a Core Genome Multilocus Sequence Typing Scheme for Whole-Genome Sequence-Based Typing of Listeria monocytogenes

Journal of clinical microbiology, 2015-09, Vol.53 (9), p.2869-2876

2015

Volltextzugriff (PDF)

Role of sentinel surveillance of candidemia: Trends in species distribution and antifungal susceptibility

Journal of clinical microbiology, 2002-10, Vol.40 (10), p.3551-3557

2002

Volltextzugriff (PDF)

1 – 25 von 498

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(481)
Mit Volltextzugriff
(439)

Publikationsform

Sprache

Englisch
(498)
Japanisch
(69)
Russisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(422)
Life Sciences & Biomedicine
(416)
Humans
(382)
Microbiology
(299)
Biological And Medical Sciences
(164)
Medical Sciences
(131)
Infectious Diseases
(129)
Mycology
(105)
Antifungal Agents - Pharmacology
(100)
Female
(92)
Male
(90)
Microbial Sensitivity Tests
(89)
Candida - Drug Effects
(80)
Epidemiology
(79)
Fundamental And Applied Biological Sciences. Psychology
(77)
Bacteriology
(70)
Adult
(68)
Miscellaneous
(64)
Child
(62)
Candida
(54)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Progress in Antifungal Susceptibility Testing of Candida spp. by Use of Clinical and Laboratory Standards Institute Broth Microdilution Methods, 2010 to 2012

Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem

Rare and emerging opportunistic fungal pathogens: Concern for resistance beyond Candida albicans and Aspergillus fumigatus

In Vivo Comparison of the Pharmacodynamic Targets for Echinocandin Drugs against Candida Species

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-Year Analysis of Susceptibilities of Candida Species to Fluconazole and Voriconazole as Determined by CLSI Standardized Disk Diffusion

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Triazoles and Six Aspergillus spp. for the CLSI Broth Microdilution Method (M38-A2 Document)

Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility Testing

Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida : Time for harmonization of CLSI and EUCAST broth microdilution methods

Correlation of MIC with Outcome for Candida Species Tested against Caspofungin, Anidulafungin, and Micafungin: Analysis and Proposal for Interpretive MIC Breakpoints

Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria

Survey of Infections Due to Staphylococcus Species: Frequency of Occurrence and Antimicrobial Susceptibility of Isolates Collected in the United States, Canada, Latin America, Europe, and the Western Pacific Region for the SENTRY Antimicrobial Surveillance Program, 1997–1999

Wild-Type MIC Distributions and Epidemiological Cutoff Values for the Echinocandins and Candida spp

In Vitro Susceptibility of Invasive Isolates of Candida spp. to Anidulafungin, Caspofungin, and Micafungin: Six Years of Global Surveillance

Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: 10.5-Year Analysis of Susceptibilities of Noncandidal Yeast Species to Fluconazole and Voriconazole Determined by CLSI Standardized Disk Diffusion Testing

Attributable Mortality of Nosocomial Candidemia, Revisited

Activities of Caspofungin, Itraconazole, Posaconazole, Ravuconazole, Voriconazole, and Amphotericin B against 448 Recent Clinical Isolates of Filamentous Fungi

Correlation of MIC with Outcome for Candida Species Tested against Voriconazole: Analysis and Proposal for Interpretive Breakpoints

Seasonality of staphylococcal infections

In Vitro Susceptibilities of Candida spp. to Caspofungin: Four Years of Global Surveillance

Activity of MGCD290, a Hos2 Histone Deacetylase Inhibitor, in Combination with Azole Antifungals against Opportunistic Fungal Pathogens

Wild-Type MIC Distributions and Epidemiological Cutoff Values for Amphotericin B, Flucytosine, and Itraconazole and Candida spp. as Determined by CLSI Broth Microdilution

In Vivo Pharmacodynamic Target Investigation for Micafungin against Candida albicans and C. glabrata in a Neutropenic Murine Candidiasis Model

Variation in Susceptibility of Bloodstream Isolates of Candida glabrata to Fluconazole According to Patient Age and Geographic Location in the United States in 2001 to 2007

Defining and Evaluating a Core Genome Multilocus Sequence Typing Scheme for Whole-Genome Sequence-Based Typing of Listeria monocytogenes

Role of sentinel surveillance of candidemia: Trends in species distribution and antifungal susceptibility

Suchergebnisse filtern